Cliford-C 600Mg/4Ml Inj belongs to the class of 'antibiotics', primarily used to treat serious bacterial infections such as lower respiratory tract infections like pneumonia, empyema, and lung abscess; gynaecological infections like endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection; intra-abdominal infections; septicaemia or sepsis (blood poisoning by bacteria), and bone and joint infections. Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly. 

Cliford-C 600Mg/4Ml Inj contains 'Clindamycin' that works by preventing bacterial protein synthesis, leading to the inhibition of bacterial growth. It shows a bacteriostatic effect that stops bacterial reproduction. Cliford-C 600Mg/4Ml Inj effectively treats infections caused by gram-positive and anaerobic (living without air) bacteria, including susceptible strains of Staphylococcus aureus, Streptococcus pneumoniae, and Clostridium perfringens.

Cliford-C 600Mg/4Ml Inj will be administered by a healthcare professional. Cliford-C 600Mg/4Ml Inj may cause side effects, although not everybody gets them. Common side effects of Cliford-C 600Mg/4Ml Inj include stomach pain, nausea, vomiting, diarrhoea, heartburn, skin rash, pain and swelling at the injection site, and vaginal itching or discharge. Most of these side effects do not require medical attention and gradually resolve over time. If these side effects persist longer, please consult your doctor.

Brief your medical history to the doctor if you are allergic to any of the components in Cliford-C 600Mg/4Ml Inj. Let your doctor know if you have any liver disease, kidney disease, yellow food dye allergy, colitis (colon inflammation), severe stomach cramps, diarrhoea, and allergic conditions (asthma, hay fever, eczema). Do not use Cliford-C 600Mg/4Ml Inj while getting vaccinated with live bacterial vaccines (typhoid vaccine) since Cliford-C 600Mg/4Ml Inj may affect the vaccine's activity. Cliford-C 600Mg/4Ml Inj should be used only with a doctor's advice during pregnancy and breastfeeding.

Cliford-C 600Mg/4Ml Inj is an antibiotic that treats severe/serious bacterial infections. It works by inhibiting bacterial protein synthesis, which inhibits bacterial growth. It shows a bacteriostatic effect, which stops bacterial reproduction but doesn't kill them. Cliford-C 600Mg/4Ml Inj effectively treats infections caused by gram-positive and anaerobic (living without air) bacteria, including susceptible strains of Staphylococcus aureus, Streptococcus pneumoniae, and Clostridium perfringens. Cliford-C 600Mg/4Ml Inj is useful in treating lower respiratory tract infections like pneumonia, empyema, and lung abscess; gynaecological infections like endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection; intra-abdominal infections; septicaemia or sepsis (blood poisoning by bacteria), and bone and joint infections.

Do not use Cliford-C 600Mg/4Ml Inj if you are allergic to any of its components. Let your doctor know if you have any liver or kidney diseases, gastrointestinal diseases (colitis, Clostridium difficile-associated diarrhoea), yellow food dye allergy, and allergic conditions (asthma, hay fever, eczema). Do not use Cliford-C 600Mg/4Ml Inj while getting vaccinated with live bacterial vaccines (typhoid vaccine) since Cliford-C 600Mg/4Ml Inj may affect the vaccine's activity. Pregnant and breastfeeding women should consult their doctor before taking Cliford-C 600Mg/4Ml Inj. Avoid alcohol consumption to prevent any undesired effects while using Cliford-C 600Mg/4Ml Inj.

• Liver and kidney function monitoring (Liver and kidney function tests) are recommended in patients with severe liver and kidney diseases.
• Clostridium difficile-associated diarrhoea (CDAD) is reported during the usage of antibiotics. Please consult your doctor if you experience prolonged diarrhoea.